| Application no. and date | 15732533.3 (espacenet) (Federated) (European Patent Register), 20150626 | | Patent/reg. no. and date | DK/EP 3160489, 20230607 | | Publication date | 20170503 | | Priority no. and date | WO PCT/EP2014/001736, 20140626, WO PCT/EP2014/002724, 20141008 | | EP pub. no. and date |
EP 3160489 20170503 | | Effective date | | | Applicant/owner | Xigen Inflammation Ltd., Arch. Makariou III
195 Neocleous House
3030 Limassol, CY | | Applicant ref. no. | | | Inventor | COMBETTE, Jean-Marc, 515 route de Terret
F-74140 Saint Cergues, FR,
DELOCHE, Catherine, 22 Avenue William-Favre
CH-1207 Genf, CH | | Representative | | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 48/00 (2006.01) , A61P 1/02 (2006.01) , A61P 13/12 (2006.01) , A61P 17/00 (2006.01) , A61P 17/06 (2006.01) , A61P 17/10 (2006.01) , A61P 19/08 (2006.01) , A61P 25/28 (2006.01) , A61P 3/04 (2006.01) , A61P 3/10 (2006.01) , A61P 41/00 (2006.01) , A61P 7/00 (2006.01) , A61P 7/04 (2006.01) , A61P 7/06 (2006.01) , A61P 9/12 (2006.01) , A61P 9/14 (2006.01) , C07K 14/47 (2006.01) , C07K 16/40 (2006.01) , C12N 15/00 (2006.01) | | Title | NEW USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES | | Int. application no. | EP2015001294 | | Int. publication no. | WO2015197194 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
